Company Overview VerifyMe, Inc. provides brand protection and precision logistics solutions for time- and temperature-sensitive products. Key Financial Figures The company reported a 2025 annual revenue of $16.4 million. Fourth-quarter revenue was $2.4 million. Earnings Per Share (EPS) is omitted as it is not provided in the source document. Additional Financial Insights VerifyMe ended 2025 […]
VerifyMe 2025 Financial Results Analysis Read More »
Company Overview Lantern Pharma is an oncology company utilizing its AI platform, RADR, to advance precision drug development. It maintains a pipeline of targeted therapies for rare and hard-to-treat cancers. Key Financial Figures For the year ended December 31, 2025, Lantern Pharma did not report any top-line revenue. The company’s net loss per common share
Lantern Pharma 2025 Financial Update Read More »
LNSR|EPS -$0.12|Rev $16.0M|Net Loss $1.5M Lensar, Inc. reported a narrower loss for the fourth quarter of 2025, posting a net loss of $1.5M as the medical device maker saw mixed results in its laser cataract surgery business. The company recorded a loss per share of $0.12, compared to a loss of $1.61 in the year-ago
Lensar, Inc. (LNSR) Reports Q4 Earnings Read More »
AI Is “New Front Door To Commerce” As Consumers Ditch Google For Chatbots Shoptalk, one of the retail and e-commerce industry’s top U.S. conferences, took place in Las Vegas last week, where Goldman analysts had one key takeaway for clients on Monday morning: AI is beginning to reshape how consumers shop. Analysts Brooke Roach and
AI Is “New Front Door To Commerce” As Consumers Ditch Google For Chatbots Read More »
China’s Quiet Gains During US-Israel War On Iran Authored by Hamza Zaman via RealClearDefense, The Iran conflict continues to protract despite President Trump’s assumption of a quick and easy victory. The goals of regime change and the decimation of the Iranian ballistic missile program remain unfulfilled, and the closure of the Strait of Hormuz further
China’s Quiet Gains During US-Israel War On Iran Read More »
JSPR|EPS -$0.32|Net Loss $9.1M Jasper Therapeutics, Inc. reported a significantly narrower loss for the fourth quarter of 2025, reflecting improved cost management at the clinical-stage biotechnology company. The firm posted a loss of $0.32 per share for the quarter, compared with a loss of $1.62 per share in the same period a year earlier, representing
Jasper Therapeutics, Inc. (JSPR) Reports Q4 Earnings Read More »
PMGM|EPS -$3.95|Net Loss $39.2M AEON Biopharma is a biopharmaceutical company advancing ABP-450 as a BOTOX® biosimilar. Recent $6 million PIPE financing and note exchanges have reduced the company’s outstanding debt by over 90%. Basic and diluted net loss per share (EPS) for 2025 was $(3.95), compared to a basic net income per share of $77.74
AEON Biopharma 2025 Financial Review Read More »
US Must Boost Domestic Uranium Enrichment To Counter Proliferation Risks The Export-Import Bank of the United States recently issued letters of interest supporting up to $4.2 billion in financing for enriched uranium sales by General Matter to utilities in Japan and South Korea. This includes up to $2.4 billion for Japanese operators and $1.8 billion
US Must Boost Domestic Uranium Enrichment To Counter Proliferation Risks Read More »
Chancellor Merz Admits A “Considerable Proportion” Of Violence In Germany Comes “From Immigrant Groups” Via Remix News, The debate over violence in German society and schools has reached a boiling point in the Bundestag, pitting Chancellor Friedrich Merz and his supporters against critics who accuse him of racism, including a Left Party politician who published
Liberal MP Labels X A “Massive Problem” For Allowing Brits To Criticize Mass Immigration Authored by Steve Watson via Modernity.news, A British Liberal Democrat MP has openly admitted what the political class really fears about Elon Musk’s X: it lets ordinary Britons speak freely about the disaster of mass immigration. In a clip that exploded
Liberal MP Labels X A “Massive Problem” For Allowing Brits To Criticize Mass Immigration Read More »
